Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.61 (
caspase-8
)
6,833
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Homophilic interactions of death effector domains (DEDs) are crucial for the signaling pathways of death receptor-mediated apoptosis. The machinery that regulates proper oligomerization and autoactivation of procaspase-8 and/or procaspase-10 during T lymphocyte activation determines whether the cells will undergo caspase-mediated apoptosis or proliferation. We screened a yeast two-hybrid library by using the DEDs contained in the prodomains of procaspase-8 and procaspase-10 and isolated a
DED-associated factor
(
DEDAF
) that interacts with several DED-containing proteins but does not itself contain a DED.
DEDAF
is highly conserved between human and mouse (98% amino acid identity) and is homologous to a nuclear regulatory protein YAF-2.
DEDAF
is expressed at the highest levels in lymphoid tissues and placenta.
DEDAF
interacts with FADD, procaspase-8, and procaspase-10 in the cytosol as well as with the DED-containing DNA-binding protein (DEDD) in the nucleus. At the cell membrane,
DEDAF
augmented the formation of CD95-FADD-
caspase-8
complexes and enhanced death receptor- as well as DED-mediated apoptosis. In the nucleus,
DEDAF
caused the DEDD protein to relocalize from subnuclear structures to a diffuse distribution in the nucleoplasm. Our data therefore suggest that
DEDAF
may be involved in the regulation of both cytoplasmic and nuclear events of apoptosis.
...
PMID:The death effector domain-associated factor plays distinct regulatory roles in the nucleus and cytoplasm. 1139